| Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer (NCT04789486) | Dana-Farber Cancer Institute | 2021-05-27 |
| FAZA PET/MRI Pancreas (NCT04395469) | University Health Network, Toronto | 2021-05-18 |
| Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer (NCT04698915) | Galera Therapeutics, Inc. | 2021-05-07 |
| Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (NCT04002479) | Alpha Tau Medical LTD. | 2020-10-20 |
| Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer (NCT04093141) | Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery | 2019-05-01 |
| EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options (NCT03602885) | Dana-Farber Cancer Institute | 2018-09-01 |
| A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma (NCT03250273) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-11-06 |
| Bioinformation Therapy for Pancreatic Cancer (NCT03239184) | Fuda Cancer Hospital, Guangzhou | 2017-09-01 |
| Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic Cancer (NCT03117556) | University of Louisville | 2017-08-31 |
| Pre-operative Treatment for Patients With Untreated Pancreatic Cancer (NCT03138720) | HonorHealth Research Institute | 2017-05-23 |
| Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer (NCT03891472) | Medical University of Silesia | 2017-01-01 |
| EUS BD vs ERCP TP for Pancreatic Cancer (NCT03063554) | Weill Medical College of Cornell University | 2016-10-18 |
| Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer (NCT02945267) | Chinese PLA General Hospital | 2016-09-01 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
| Improving Informed Consent for Palliative Chemotherapy (NCT02282722) | Dana-Farber Cancer Institute | 2015-06-10 |
| BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer (NCT03627390) | Meabco A/S | 2014-12-19 |
| RFA RCT for Pancreatic or Bile Duct Cancer (NCT02166190) | Weill Medical College of Cornell University | 2014-06-01 |
| Regional Versus Systemic Chemotherapy in the Treatment of Unresectable Pancreatic Cancer (NCT01665625) | Air Force Military Medical University, China | 2012-08-01 |
| Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer. (NCT02035072) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2010-11-01 |
| Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer (NCT01304160) | Centre hospitalier de l'Université de Montréal (CHUM) | 2010-09-01 |